173 related articles for article (PubMed ID: 11161389)
1. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells.
Marko D; Schätzle S; Friedel A; Genzlinger A; Zankl H; Meijer L; Eisenbrand G
Br J Cancer; 2001 Jan; 84(2):283-9. PubMed ID: 11161389
[TBL] [Abstract][Full Text] [Related]
2. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
[TBL] [Abstract][Full Text] [Related]
3. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
4. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.
Schultz C; Link A; Leost M; Zaharevitz DW; Gussio R; Sausville EA; Meijer L; Kunick C
J Med Chem; 1999 Jul; 42(15):2909-19. PubMed ID: 10425100
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells.
Lee JW; Moon MJ; Min HY; Chung HJ; Park EJ; Park HJ; Hong JY; Kim YC; Lee SK
Bioorg Med Chem Lett; 2005 Sep; 15(17):3948-52. PubMed ID: 15993584
[TBL] [Abstract][Full Text] [Related]
6. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells.
Kameswaran TR; Ramanibai R
Biomed Pharmacother; 2009 Feb; 63(2):146-54. PubMed ID: 18450412
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
8. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
9. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
10. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Hoessel R; Leclerc S; Endicott JA; Nobel ME; Lawrie A; Tunnah P; Leost M; Damiens E; Marie D; Marko D; Niederberger E; Tang W; Eisenbrand G; Meijer L
Nat Cell Biol; 1999 May; 1(1):60-7. PubMed ID: 10559866
[TBL] [Abstract][Full Text] [Related]
11. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell lines.
De Marco C; Zaffaroni N; Comijn E; Tesei A; Zoli W; Peters GJ
Int J Oncol; 2007 Oct; 31(4):907-13. PubMed ID: 17786324
[TBL] [Abstract][Full Text] [Related]
13. Discovery and evaluation of dual CDK1 and CDK2 inhibitors.
Payton M; Chung G; Yakowec P; Wong A; Powers D; Xiong L; Zhang N; Leal J; Bush TL; Santora V; Askew B; Tasker A; Radinsky R; Kendall R; Coats S
Cancer Res; 2006 Apr; 66(8):4299-308. PubMed ID: 16618755
[TBL] [Abstract][Full Text] [Related]
14. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
15. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
16. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
[TBL] [Abstract][Full Text] [Related]
17. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
[TBL] [Abstract][Full Text] [Related]
18. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
Choi EJ; Kim GH
J Nutr Biochem; 2009 Apr; 20(4):285-90. PubMed ID: 18656338
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of novel indirubin derivatives in rat tumor model.
Kim SA; Kim YC; Kim SW; Lee SH; Min JJ; Ahn SG; Yoon JH
Clin Cancer Res; 2007 Jan; 13(1):253-9. PubMed ID: 17200363
[TBL] [Abstract][Full Text] [Related]
20. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]